126 related articles for article (PubMed ID: 2275156)
1. [The use of antioxidants in patients with chronic diseases of the hepatobiliary system (a review of the literature)].
Epishin AV; Rudiak GI
Vrach Delo; 1990 Apr; (4):24-7. PubMed ID: 2275156
[No Abstract] [Full Text] [Related]
2. [Use of Cholesol in the therapy of chronic diseases of the hepatobiliary system in children].
Lapshin VF
Pediatriia; 1986 Apr; (4):61-3. PubMed ID: 3714425
[No Abstract] [Full Text] [Related]
3. [Antioxidant activity of hepatotropic preparations in the treatment of chronic diseases of the liver].
Loginov AS; Matiushin BN; Sukhareva GV; Tkachev VD
Ter Arkh; 1988; 60(8):74-7. PubMed ID: 3227482
[TBL] [Abstract][Full Text] [Related]
4. [The effectiveness of using immunocorrective agents and antioxidants in pregnant women with chronic pathology of the hepatobiliary system].
Frolov VM; Germanov VT; Peresadin NA
Akush Ginekol (Mosk); 1993; (3):51-3. PubMed ID: 8048690
[No Abstract] [Full Text] [Related]
5. [Odeston in treatment of chronic diseases of hepatobiliary system].
Nasonova SV; Lebedeva OI
Voen Med Zh; 2001 Feb; 322(2):49-53. PubMed ID: 11338822
[No Abstract] [Full Text] [Related]
6. [Natural antioxidants as hepatoprotectors].
Buniatian ND; Gerasimova OA; Sakharova TS; Iakovleva LV
Eksp Klin Farmakol; 1999; 62(2):64-7. PubMed ID: 10340135
[No Abstract] [Full Text] [Related]
7. Therapeutic use of cytoprotective agents in canine and feline hepatobiliary disease.
Webster CR; Cooper J
Vet Clin North Am Small Anim Pract; 2009 May; 39(3):631-52. PubMed ID: 19524797
[TBL] [Abstract][Full Text] [Related]
8. [Clinical importance of studying the free biliary acids of the bile in certain diseases of the hepatobiliary system].
Abramzon MA; Popova RA; Ripatti PO
Vrach Delo; 1975 Mar; (3):72-4. PubMed ID: 1121842
[No Abstract] [Full Text] [Related]
9. [Characteristics of carbohydrate metabolism in children with chronic hepatobiliary system diseases].
Smiian IS; Slobodian IM; Khodorchuk NIa; Babinets' TS
Pediatr Akus Ginekol; 1975; (4):17-9. PubMed ID: 1064835
[No Abstract] [Full Text] [Related]
10. [Disruption of the electrolyte and microelement composition of gastric juice and bile in patients with chronic diseases of the hepatobiliary system].
Gubergrits AIa; Revutskiĭ BI; Shmakov VN
Vrach Delo; 1989 May; (5):64-6. PubMed ID: 2773439
[TBL] [Abstract][Full Text] [Related]
11. Possible application of melatonin treatment in human diseases of the biliary tract.
Baiocchi L; Zhou T; Liangpunsakul S; Ilaria L; Milana M; Meng F; Kennedy L; Kusumanchi P; Yang Z; Ceci L; Glaser S; Francis H; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G651-G660. PubMed ID: 31509434
[TBL] [Abstract][Full Text] [Related]
12. [Antibacterial therapy in diseases of the liver and biliary tract (a review of the literature)].
Dederer IuM; Krylova NP
Khirurgiia (Mosk); 1988 Jan; (1):106-8. PubMed ID: 3280856
[No Abstract] [Full Text] [Related]
13. Oxidative stress and liver disease.
Webb C; Twedt D
Vet Clin North Am Small Anim Pract; 2008 Jan; 38(1):125-35, v. PubMed ID: 18249245
[TBL] [Abstract][Full Text] [Related]
14. Cytoprotective effects of alpha tocopherol against liver injury induced by extrahepatic biliary obstruction.
Cantürk NZ; Canturk Z; Utkan NZ; Yenisey C; Ozbilim G; Yildirir C; Yalman Y
East Afr Med J; 1998 Feb; 75(2):77-80. PubMed ID: 9640827
[TBL] [Abstract][Full Text] [Related]
15. [The clinical significance of the enzymatic system utilizing active forms of oxygen in chronic liver diseases].
Loginov AS; Matiushin BN
Ter Arkh; 1994; 66(4):65-8. PubMed ID: 8016735
[TBL] [Abstract][Full Text] [Related]
16. [Lipid peroxidation in aseptic inflammation and the action of phlogolytics and antioxidants].
Pidzemskiĭ EL; Tul'bovich GA; Goleneva AF; Koshniakova NV
Patol Fiziol Eksp Ter; 1990; (1):19-21. PubMed ID: 2352773
[No Abstract] [Full Text] [Related]
17. [Prevention and treatment of acute liver failure in mechanical jaundice by using a complex of natural antioxidants].
Gavrilenko GA; Gerasimova AM; Ovchinnikov KG; Strel'tsov IuP
Anesteziol Reanimatol; 1985; (2):35-9. PubMed ID: 4003837
[No Abstract] [Full Text] [Related]
18. [Galstena therapy of some hepatobiliary diseases].
Munushkin ON
Klin Med (Mosk); 2001; 79(12):38-41. PubMed ID: 11840810
[TBL] [Abstract][Full Text] [Related]
19. [Antioxidants in experimental and clinical hepatology].
Khvorostinka VN; Moiseenko TA
Vrach Delo; 1991 Jul; (7):17-22. PubMed ID: 1771826
[No Abstract] [Full Text] [Related]
20. [Clinical observations on the use of a phosphatidylcholine-based preparation in patients with hepatobiliary diseases of surgical significance].
Battistini C; Lampugnani R
Minerva Dietol Gastroenterol; 1977; 23(3):219-36. PubMed ID: 618097
[No Abstract] [Full Text] [Related]
[Next] [New Search]
